SuperworthCo-Diagnostics EV/EBIT CODX
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2020.
- Today, Oct 23, 2026
- n/m
- an operating loss
- Last meaningful
- 0.2×
- Mar 2023
- 6-year median
- 3.3×
- 6-year range
- 0.2× to 42.4×
- Peer median
- 4.9×
Co-Diagnostics has no meaningful EV/EBIT today: it made an operating loss of $49M over the last twelve months.
It was last meaningful in Mar 2023, at 0.2×.
On the days it had one over the last 6 years, its median was 3.3×, from 0.2× in Sep 2022 to 42.4× in Aug 2020.
EV/EBIT over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2023 | 0.2× | 0.2× | 0.8× |
| 2022 | 1.0× | 0.2× | 3.6× |
| 2021 | 3.4× | 3.0× | 18.9× |
| 2020 | 9.8× | 9.8× | 42.4× |
Against its peers
Companies in Healthcare nearest Co-Diagnostics' size, closest first, today.
| Company | EV/EBIT |
|---|---|
| CODXCo-Diagnostics | n/m |
| OXBROXBRIDGE RE HOLDINGS | n/m |
| EDUCEducational Development | n/m |
| GTIMGood Times Restaurants | 4.9× |
| MDRRMedalist Diversified | 2.1× |
| BCGBinah Capital | 1.5× |
| VIPVulcan Infrastructure & Power | n/m |
| MXCMexco Energy | 12.8× |
| CKXCKX Lands | n/m |
| MSGMMotorsport Games | 6.5× |
| ATCHAtlasClear | n/m |
| Peer median | 4.9× |
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Co-Diagnostics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.